siponimod

This page shows the latest siponimod news and features for those working in and with pharma, biotech and healthcare.

Novartis: pipeline will generate 60 filings in three years

Those are headed by Mayzent (siponimod) – due to launch in the first quarter of 2019 – which it says is the “first and only drug proven to delay progression” in patients with

Latest news

Novartis files for approval of MS drug in EU, US

Siponimod also seemed to have a meaningful benefit on patients’ cognitive processing speed in the study. ... Siponimod has an opportunity to tap into a niche not fully addressed by rival therapies.
Novartis drug works in secondary progressive MS

Orally-active siponimod reduces risk of disability progression. . A follow-up to Novartis' multiple sclerosis therapy Gilenya has been shown to work in a tough-to-treat form of multiple sclerosis ... MS). The new drug candidate - called siponimod

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

Drug launches to watch in 2019

4. Mayzent – a latest addition to competitive MS market. Novartis’ Mayzent (siponimod) is expected to be launched in the US in Q1 for multiple sclerosis, with an EU launch to follow
Tackling a formidable foe

Novartis has announced positive phase III trial data for siponimod, a drug for secondary progressive MS, which reduced the risk of a patient’s disability worsening by 21% after three months

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Senior Medical Writer: Great salary and benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Project Manager/ Account Manager: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Director, Medical Education: Salary TBC

Senior Medical Writer: Up to £50, 000 with Benefits

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Senior Medical Writer: Salary TBC

Digital Account Director: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Jet Off with Maloff Protect

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age: Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge: Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis: Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....